Link to this page
Bilingual Ontology of Alzheimer's Disease and Related Diseases
| Preferred Name | Dactinomycin | |
| Synonyms |
Actinomycin D actinomycin-D ACT-D Meractinomycin Actinomycin I1 Actinomycin X 1 Dactinomycin chemical actinomycin C1 Actinomycin-[thr-val-pro-sar-meval] Actinomycin IV DACT Actinomycin A IV Dactinomycine |
|
| Definitions |
A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) (source : MSH) |
|
| ID |
http://doe-generated-ontology.com/OntoAD#C0010934 |
|
| altLabel |
Actinomycin D actinomycin-D ACT-D Meractinomycin Actinomycin I1 Actinomycin X 1 Dactinomycin chemical actinomycin C1 Actinomycin-[thr-val-pro-sar-meval] Actinomycin IV DACT Actinomycin A IV Dactinomycine
|
|
| contraindicated_drug | ||
| definition |
A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) (source : MSH)
|
|
| hiddenLabel |
Dactinomycin
|
|
| may_treat | ||
| prefixIRI |
OntoAD:C0010934
|
|
| prefLabel |
Dactinomycin
|
|
| subClassOf |
http://doe-generated-ontology.com/OntoAD#C0033671 http://doe-generated-ontology.com/OntoAD#C0001259 http://doe-generated-ontology.com/OntoAD#C0279516 |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |